Rinvoq ER 30 MG tablet UU 30S
Ended Awarded Last action
- Contract number
- SPE2DR26FM9Z4
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $41,478
Award facts
- Contract value 100% obligated
- $41,478.37 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., was awarded a delivery order valued at $41,478.37 by the Defense Logistics Agency on January 14, 2026, for the supply of RINVOQ ER 30 mg tablets in quantities of 30 units. The award is a firm fixed-price delivery order with an ultimate completion date of January 15, 2026, and the work will be performed in Conshohocken, Pennsylvania. This award was not designated as a set-aside contract, indicating it was awarded through open and full competition.
This delivery order represents a task order under Amerisourcebergen Drug Corp's larger Indefinite Delivery Contract with the Defense Logistics Agency Troop Support Medical (valued at $999,999,999.00 through December 2026), which serves as a comprehensive global pharmaceutical support vehicle for the military healthcare system. The IDC enables the company to supply a broad range of pharmaceutical products, medical supplies, specialty medications, and generic drugs to support military treatment facilities and other federal health programs worldwide. RINVOQ, a JAK inhibitor used primarily for rheumatoid arthritis and other inflammatory conditions, represents the type of specialized pharmaceutical commodity the company routinely delivers under its federal contract portfolio.
Quick answers
Who was awarded contract SPE2DR26FM9Z4?
SPE2DR26FM9Z4 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 14, 2026.
How much is contract SPE2DR26FM9Z4 worth?
The government has obligated $41,478 on SPE2DR26FM9Z4.
Is contract SPE2DR26FM9Z4 an order under another contract?
Yes. SPE2DR26FM9Z4 is a delivery order under SPE2DR25D2211, an indefinite delivery contract.
Was contract SPE2DR26FM9Z4 competed?
The extent of competition for SPE2DR26FM9Z4 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award